Gastroenterology

Gastroenterology

Volume 110, Issue 4, April 1996, Pages 1225-1237
Gastroenterology

Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile

https://doi.org/10.1053/gast.1996.v110.pm8613013Get rights and content

Abstract

BACKGROUND & AIMS: Ursodeoxycholic acid prevents gallstone formation in selected patients. The aim of this study was to examine whether decreased concentration and nucleation-promoting activity of various proteins contribute to this beneficial effect. METHODS: Gallbladder bile of 13 patients with cholesterol gallstones treated with ursodeoxycholic acid (10 mg/kg(-1)/day(-1)) and of 13 untreated patients were compared. RESULTS: Total protein concentration in gallbladder bile (2.8 +/- 0.6 vs. 6.7 +/- 1.3 mg/mL; P=0.008) and concanavalin A-binding fraction (0.16 +/- 0.03 vs. 0.42 +/- 0.07 mg/mL; P=0.003) were strongly decreased by ursodeoxycholic acid therapy. Significant decreases were also found for gallbladder bile alpha1-acid glycoprotein, haptoglobin, immunoglobulin (Ig) A, IgG, gamma-glutamyl transpeptidase, and aminopeptidase N but not for IgM, mucin, or beta- glucuronidase. Decreases were most pronounced for proteins of canalicular membrane origin. Gallbladder bile total protein correlated with cholesterol saturation index (r=0.54; P=0.0047) but not with bile salt hydrophobicity index. Crystallization-promoting activity of the concanavalin A-binding fraction (assessed by nephelometry and microscopic examination) was also significantly decreased by ursodeoxycholic acid. CONCLUSIONS: Ursodeoxycholic acid strongly decreases levels of various proteins and nucleation-promoting activity in bile. (Gastroenterology 1996 Apr;110(4):1225-37)

References (0)

Cited by (37)

  • Bile acid preparation and comprehensive analysis by high performance liquid chromatography–high-resolution mass spectrometry

    2017, Clinica Chimica Acta
    Citation Excerpt :

    Due to the presence of isobaric BAs in natural samples (Fig. 1) it is essential to perform an adequate chromatographic separation for the determination of the entire profile of BAs. Chromatographic analysis of BAs has primarily been performed using gas chromatography of derivatized compounds and single ion recording mass spectrometry [10]. With the development of modern liquid chromatography (LC), together with electrospray ionization (ESI) and triple quadrupole mass spectrometers, LC-tandem mass spectrometry (MS-MS) methods were introduced for BA analysis.

  • Pathogenesis of gallstones

    2010, Gastroenterology Clinics of North America
    Citation Excerpt :

    Also, decreasing biliary mucin content with aspirin decreases risk of gallstones in the prairie dog model29 and risk of gallstone recurrence after nonsurgical treatment in humans.30 Ursodeoxycholic acid also decreases biliary mucin contents.31 Meal ingestion induces considerable gallbladder emptying (up to 70%–80% of fasting gallbladder volumes) by releasing the hormone cholecystokinin from the upper intestine.

  • Pathways of cholesterol crystallization in model bile and native bile

    2003, Digestive and Liver Disease
    Citation Excerpt :

    The crystal detection time indicates the first day when a given crystal habit appears in bile as confirmed by light (polarizing) microscopy (generally 100× magnification). Studies from our group have carefully described this phenomenon in fresh samples as well as in ex vivo incubated biles [24,45]. As bile is a complex mixture, the contribution of each individual component with respect to cholesterol crystallization will be addressed in the following paragraphs.

  • Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles

    2002, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
View all citing articles on Scopus
View full text